Bausch Health Cos Return on Tangible Equity 2010-2024 | BHC
Current and historical return on tangible equity values for Bausch Health Cos (BHC) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Bausch Health Cos Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2024-09-30 |
$-0.18B |
$-17.07B |
1.02% |
| 2024-06-30 |
$-0.47B |
$-17.26B |
2.67% |
| 2024-03-31 |
$-0.46B |
$-17.52B |
2.60% |
| 2023-12-31 |
$-0.59B |
$-17.72B |
3.41% |
| 2023-09-30 |
$-0.96B |
$-18.15B |
5.59% |
| 2023-06-30 |
$-0.19B |
$-16.66B |
1.09% |
| 2023-03-31 |
$-0.36B |
$-16.99B |
2.04% |
| 2022-12-31 |
$-0.23B |
$-17.09B |
1.25% |
| 2022-09-30 |
$0.25B |
$-17.64B |
-1.36% |
| 2022-06-30 |
$0.04B |
$-18.34B |
-0.22% |
| 2022-03-31 |
$-0.41B |
$-19.20B |
2.05% |
| 2021-12-31 |
$-0.95B |
$-19.44B |
4.70% |
| 2021-09-30 |
$-1.17B |
$-19.87B |
5.70% |
| 2021-06-30 |
$-1.29B |
$-20.76B |
6.15% |
| 2021-03-31 |
$-1.02B |
$-20.61B |
4.80% |
| 2020-12-31 |
$-0.56B |
$-20.88B |
2.60% |
| 2020-09-30 |
$-1.92B |
$-21.43B |
8.80% |
| 2020-06-30 |
$-2.04B |
$-21.84B |
9.38% |
| 2020-03-31 |
$-1.89B |
$-21.97B |
8.68% |
| 2019-12-31 |
$-1.79B |
$-22.19B |
8.22% |
| 2019-09-30 |
$-0.62B |
$-21.14B |
2.83% |
| 2019-06-30 |
$-0.92B |
$-21.67B |
4.13% |
| 2019-03-31 |
$-1.62B |
$-22.03B |
7.18% |
| 2018-12-31 |
$-4.15B |
$-22.33B |
18.13% |
| 2018-09-30 |
$-3.29B |
$-22.71B |
14.00% |
| 2018-06-30 |
$-1.64B |
$-23.12B |
6.73% |
| 2018-03-31 |
$-0.81B |
$-23.37B |
3.10% |
| 2017-12-31 |
$2.40B |
$-24.86B |
-8.71% |
| 2017-09-30 |
$1.38B |
$-26.17B |
-4.71% |
| 2017-06-30 |
$-1.14B |
$-29.38B |
3.67% |
| 2017-03-31 |
$-1.41B |
$-29.95B |
4.35% |
| 2016-12-31 |
$-2.41B |
$-31.42B |
7.15% |
| 2016-09-30 |
$-2.28B |
$-33.69B |
6.57% |
| 2016-06-30 |
$-1.01B |
$-34.45B |
2.92% |
| 2016-03-31 |
$-0.76B |
$-35.17B |
2.21% |
| 2015-12-31 |
$-0.29B |
$-35.61B |
1.00% |
| 2015-09-30 |
$0.60B |
$-33.29B |
-2.47% |
| 2015-06-30 |
$0.82B |
$-33.82B |
-4.16% |
| 2015-03-31 |
$1.00B |
$-14.14B |
-6.56% |
| 2014-12-31 |
$0.88B |
$-15.24B |
-5.47% |
| 2014-09-30 |
$0.50B |
$-15.86B |
-3.02% |
| 2014-06-30 |
$-0.75B |
$-15.82B |
4.36% |
| 2014-03-31 |
$-0.86B |
$-17.41B |
5.61% |
| 2013-12-31 |
$-0.87B |
$-17.37B |
6.32% |
| 2013-09-30 |
$-1.08B |
$-17.77B |
8.96% |
| 2013-06-30 |
$-0.10B |
$-8.87B |
1.02% |
| 2013-03-31 |
$-0.13B |
$-10.81B |
1.39% |
| 2012-12-31 |
$-0.12B |
$-10.73B |
1.35% |
| 2012-09-30 |
$0.03B |
$-8.05B |
-0.37% |
| 2012-06-30 |
$0.06B |
$-8.15B |
-0.85% |
| 2012-03-31 |
$0.14B |
$-7.46B |
-2.10% |
| 2011-12-31 |
$0.16B |
$-7.29B |
-2.62% |
| 2011-09-30 |
$0.07B |
$-6.20B |
-1.34% |
| 2011-06-30 |
$-0.18B |
$-5.65B |
3.65% |
| 2011-03-31 |
$-0.20B |
$-5.18B |
5.80% |
| 2010-12-31 |
$-0.21B |
$-4.46B |
9.67% |
| 2010-09-30 |
$-0.10B |
$-4.09B |
9.84% |
| 2010-06-30 |
$0.14B |
$-0.00B |
-174.55% |
| 2010-03-31 |
$0.13B |
$-0.06B |
-91.31% |
| 2009-12-31 |
$0.18B |
$-0.08B |
-448.41% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$3.597B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
